Indoor Harvest Corp (INQD)

[elbiatcho1]

Cell>Point ? Conflict of interest?

Jerry Bryant, President of Vyripharm Enterprises/Biowhatever.

Jerry Bryant, CTO of Cell>Point.

https://www.linkedin.com/in/jerry-bryant-25ab5814/

Cell>Point enters into license agreement with Vyripharm Biopharmaceuticals for the use of Cell>Point’s In-Situ Hydrogel, N4 Technology and Oligosaccharide (Dual Agent) Technology
Published August 25, 2016 | By admin

CENTENNIAL, Colo., August 24, 2016 – Cell>Point today announced it has entered into license
agreements with Vyripharm Biopharmaceuticals for the use of its In-Situ Hydrogel, N4 Technology and
Oligosaccharide (Dual Agent) Technology to develop applications in combination with cannabinoids for
nuclear imaging and therapeutic applications for neurologic disorders including, but not limited to, posttraumatic
stress disorder (“PTSD”), epilepsy and other acute/chronic disorders. As part of the license
Cell>Point will own a majority interest in Vyripharm Biopharmaceuticals.



http://cellpointweb.com/cellpoint-enters-into-license-agreement-with-vyripharm-biopharmaceuticals-for-the-use-of-in-situ-hydrogel-n4-technology-and-oligosaccharide-dual-agent-technology/